Nouvelle déclaration d'incident
No de la demande: 2010-0620
Numéro de référence du titulaire d'homologation: 90089352
Nom du titulaire (nom légal complet, aucune abbréviation): Monsanto Canada Inc.
Adresse: 350 Albert St., Suite 315
Ville: Ottawa
État: ON
Pays: CANADA
Code postal /Zip: K1R 1A4
Incident chez un animal domestique
Pays: UNITED STATES
État: OHIO
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 71995-29
Nom du produit: Roundup Weed and Grass Killer Concentrate Plus
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 71995-29
Nom du produit:
Liquide
Oui
Inconnu
Site: Res. - Out Home / Rés - à l'ext.maison
Inconnu
Autre
Dog / Chien
unknown
1
Homme
1
30
lbs
Inconnu
Unknown / Inconnu
>3 days <=1 wk / >3 jours <=1 sem
Système
Persisted until death
Non
Non
Mort
Contact treat.area/Contact surf. traitée
(p.ex. description des symptômes tels que la fréquence et la gravité
Roundup Weed and Grass Killer Concentrate Plus (observed agent id) Possible exposure occurred on Aug 02, 2009 at 12:00 PM CDT (not specific ). Exposure involved 0.0 Not App (not specific) orally. The exposure was accidental, and occurred at animal owner yard. The agent was obtained from Other Retailer. The lot number was DNA. The expiration date was null. [Note : Owner used the diluted product 1 week ago. Owner thinks the product was dry before the dog had access. Starting 2 days ago, the dog began to vomit, have diarrhea, is lethargic and drooling excessively. Owner has been forcing food and water down the dog, but the dog is unable to hold anything down. (by (name) on Aug 08, 2009 at 12:26 PM)] Because the amount was unknown consistent, the patient was considered to be at unknown risk of developing clinical signs. If signs develop, there is low risk that those signs will be life-threatening. [Note : At most would expect mild self-limiting GI upset. Signs consistent with more severe gastrointestinal disease (viral, bacterial, etc.). (by (name) on Aug 12, 2009 at 12:20 PM)]
Mort
Because the amount was unknown consistent, the patient was considered to be at unknown risk of developing clinical signs. If signs develop, there is low risk that those signs will be life-threatening. [Note : At most would expect mild self-limiting GI upset. Signs consistent with more severe gastrointestinal disease (viral, bacterial, etc.). (by SG on Aug 12, 2009 at 12:20 PM)]